Table 2

Number of patients in the general population cohort with prior statin prescribing stratified by predicted 10-year CVD risks

Risk scoreTime period10-year CVD risk as predicted by risk score (%)No prior statin use
n patients (%)
Prior statin use
n patients (%)
Framingham risk score<2007<5794744 (99.5)3898 (0.5)
5–10519859 (98.1)10300 (1.9)
10–15329159 (96.2)12940 (3.8)
15–20202504 (94.6)11447 (5.4)
≥20319089 (92.8)24757 (7.2)
≥2007<5733476 (98.6)10686 (1.4)
5–10368689 (94.1)22936 (5.9)
10–15181755 (87.9)24977 (12.1)
15–2089542 (80.8)21296 (19.2)
≥2088469 (70.3)37454 (29.7)
ASSIGN risk score<2007<5909040 (99.4)5146 (0.6)
5–10539327 (97.7)12974 (2.3)
10–15266315 (95.3)13101 (4.7)
15–20173180 (94.1)10860 (5.9)
≥20277493 (92.9)21260 (7.1)
≥2007<5820316 (98.4)13377 (1.6)
5–10370639 (93.0)27994 (7.0)
10–15145305 (84.4)26787 (15.6)
15–2068952 (76.7)20999 (23.3)
≥2056720 (66.8)28191 (33.2)
QRISK2 risk score<2007<51149295 (99.2)9128 (0.8)
5–10354037 (96.7)11927 (3.3)
10–15212654 (94.9)11453 (5.1)
15–20172081 (94.5)10014 (5.5)
≥20277287 (93.0)20818 (7.0)
≥2007<5969202 (98.0)19526 (2.0)
5–10230873 (90.7)23748 (9.3)
10–15117838 (83.9)22529 (16.1)
15–2070006 (78.5)19172 (21.5)
≥2074014 (69.6)32374 (30.4)
Any of the three risk scores (highest estimate)<2007<5760603 (99.6)3136 (0.4)
5–10486724 (98.3)8582 (1.7)
10–15299741 (96.4)11165 (3.6)
15–20216194 (95.1)11231 (4.9)
≥20402093 (93.2)29228 (6.8)
≥2007<5701025 (98.8)8450 (1.2)
5–10354980 (94.9)18949 (5.1)
10–15183877 (89.1)22419 (10.9)
15–20103799 (82.8)21592 (17.2)
≥20118251 (72.0)45939 (28.0)
  • GP, general practitioner.